TWST May 2024 32.500 call
- Business Wire
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
SOUTH SAN FRANCISCO, Calif., May 13, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Twist Multiplexed Gene Fragments (MGFs), pools of directly synthesized double-stranded DNA (dsDNA) up to 500 base pairs in length with no limit on sequence number to enable high throughput screening applications.
- Business Wire
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., May 08, 2024--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company"), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 87,200 restricted stock units ("RSUs") to 26 recently hired individuals as an inducement material to their acceptance of employment with Twist. The employment inducem
- Simply Wall St.
Earnings Update: Twist Bioscience Corporation (NASDAQ:TWST) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Twist Bioscience Corporation ( NASDAQ:TWST ) defied analyst predictions to release its second-quarter results, which...
